19-11447525-AGAGGAGGAGGAGGAGGAG-AGAGGAGGAG
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBS1BS2
The NM_001289104.2(PRKCSH):c.960_968delGGAGGAGGA(p.Glu321_Glu323del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000478 in 1,578,224 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00041 ( 0 hom., cov: 0)
Exomes 𝑓: 0.00049 ( 0 hom. )
Consequence
PRKCSH
NM_001289104.2 disruptive_inframe_deletion
NM_001289104.2 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.27
Publications
11 publications found
Genes affected
PRKCSH (HGNC:9411): (PRKCSH beta subunit of glucosidase II) This gene encodes the beta-subunit of glucosidase II, an N-linked glycan-processing enzyme in the endoplasmic reticulum. The encoded protein is an acidic phosphoprotein known to be a substrate for protein kinase C. Mutations in this gene have been associated with the autosomal dominant polycystic liver disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
PRKCSH Gene-Disease associations (from GenCC):
- polycystic liver disease 1Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, Orphanet, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -17 ACMG points.
BP3
Nonframeshift variant in repetitive region in NM_001289104.2
BP6
Variant 19-11447525-AGAGGAGGAG-A is Benign according to our data. Variant chr19-11447525-AGAGGAGGAG-A is described in ClinVar as [Likely_benign]. Clinvar id is 713728.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000408 (61/149622) while in subpopulation SAS AF = 0.00214 (10/4678). AF 95% confidence interval is 0.00116. There are 0 homozygotes in GnomAd4. There are 35 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check.
BS2
High AC in GnomAd4 at 61 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000408 AC: 61AN: 149514Hom.: 0 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
61
AN:
149514
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00117 AC: 205AN: 175324 AF XY: 0.00127 show subpopulations
GnomAD2 exomes
AF:
AC:
205
AN:
175324
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000485 AC: 693AN: 1428602Hom.: 0 AF XY: 0.000497 AC XY: 353AN XY: 709860 show subpopulations
GnomAD4 exome
AF:
AC:
693
AN:
1428602
Hom.:
AF XY:
AC XY:
353
AN XY:
709860
show subpopulations
African (AFR)
AF:
AC:
11
AN:
32844
American (AMR)
AF:
AC:
39
AN:
41912
Ashkenazi Jewish (ASJ)
AF:
AC:
17
AN:
25456
East Asian (EAS)
AF:
AC:
52
AN:
39094
South Asian (SAS)
AF:
AC:
113
AN:
83886
European-Finnish (FIN)
AF:
AC:
5
AN:
51596
Middle Eastern (MID)
AF:
AC:
3
AN:
5526
European-Non Finnish (NFE)
AF:
AC:
415
AN:
1089212
Other (OTH)
AF:
AC:
38
AN:
59076
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.414
Heterozygous variant carriers
0
30
60
89
119
149
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.000408 AC: 61AN: 149622Hom.: 0 Cov.: 0 AF XY: 0.000480 AC XY: 35AN XY: 72898 show subpopulations
GnomAD4 genome
AF:
AC:
61
AN:
149622
Hom.:
Cov.:
0
AF XY:
AC XY:
35
AN XY:
72898
show subpopulations
African (AFR)
AF:
AC:
14
AN:
40622
American (AMR)
AF:
AC:
3
AN:
15092
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3436
East Asian (EAS)
AF:
AC:
8
AN:
5054
South Asian (SAS)
AF:
AC:
10
AN:
4678
European-Finnish (FIN)
AF:
AC:
0
AN:
10160
Middle Eastern (MID)
AF:
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
AC:
26
AN:
67346
Other (OTH)
AF:
AC:
0
AN:
2052
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Aug 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
PRKCSH: BS1, BS2 -
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.